Feeds › Ownership stakes (13D / 13G)
Ownership stakes (13D / 13G)
Investors who own more than 5% of a company, from activists (13D) to passive holders (13G).
About this data
- What it is
- An investor who owns more than 5% of a public company must say so. Investors who may try to influence the company, such as activists, file the longer Schedule 13D; passive holders file the shorter Schedule 13G.
- Who files it
- The investor, within days of crossing 5%, and again whenever the stake changes materially.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- 13G filings are far more common than 13D. A 13D usually means the investor intends to push for changes, so it tends to get more attention.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Filings per day, last 30 days
13D (activist) 13G (passive)
Latest ownership filings
Showing: ticker NSPR
| Filed | ScheduleBoth report a stake of more than 5%. A 13D is filed by investors who may try to influence the company, such as activists; a 13G by passive holders. | Company | Investor | Shares | % of shares | Filing |
|---|---|---|---|---|---|---|
| May 15, 2026 | SCHEDULE 13G/A (amended) | NSPR InspireMD Inc. | Daniel Mack | 4.82M | 10.0% | SCHEDULE 13G/A ↗ |
| May 15, 2026 | SCHEDULE 13G/A (amended) | NSPR InspireMD Inc. | Wilmot B. Harkey | 4.82M | 10.0% | SCHEDULE 13G/A ↗ |
| May 15, 2026 | SCHEDULE 13G/A (amended) | NSPR InspireMD Inc. | Nantahala Capital Management, LLC | 4.82M | 10.0% | SCHEDULE 13G/A ↗ |
| May 15, 2026 | SCHEDULE 13G/A (amended) | NSPR InspireMD Inc. | Venkataraman Balaji | 2.35M | 5.0% | SCHEDULE 13G/A ↗ |
| May 15, 2026 | SCHEDULE 13G/A (amended) | NSPR InspireMD Inc. | Morgan Adam | 2.35M | 5.0% | SCHEDULE 13G/A ↗ |
| May 15, 2026 | SCHEDULE 13G/A (amended) | NSPR InspireMD Inc. | Velan Capital Management LLC | 2.35M | 5.0% | SCHEDULE 13G/A ↗ |
| May 15, 2026 | SCHEDULE 13G/A (amended) | NSPR InspireMD Inc. | Velan Capital Investment Management LP | 2.35M | 5.0% | SCHEDULE 13G/A ↗ |
| May 15, 2026 | SCHEDULE 13G/A (amended) | NSPR InspireMD Inc. | Velan Capital Holdings LLC | 2.35M | 5.0% | SCHEDULE 13G/A ↗ |
| May 15, 2026 | SCHEDULE 13G/A (amended) | NSPR InspireMD Inc. | Velan Capital Master Fund LP | 2.35M | 5.0% | SCHEDULE 13G/A ↗ |
| Apr 24, 2026 | SCHEDULE 13D | NSPR InspireMD Inc. | Marvin Slosman | 2.56M | 5.2% | SCHEDULE 13D ↗ |
| Feb 17, 2026 | SCHEDULE 13G | NSPR InspireMD Inc. | OrbiMed Capital GP IX LLC | 2.88M | 6.8% | SCHEDULE 13G ↗ |
| Feb 17, 2026 | SCHEDULE 13G | NSPR InspireMD Inc. | Orbimed Advisors LLC | 3.13M | 7.4% | SCHEDULE 13G ↗ |
| Feb 11, 2026 | SCHEDULE 13G/A (amended) | NSPR InspireMD Inc. | Rosalind Opportunities Fund I L.P. | 1.50M | 1.0% | SCHEDULE 13G/A ↗ |
| Feb 11, 2026 | SCHEDULE 13G/A (amended) | NSPR InspireMD Inc. | Rosalind Master Fund L.P. | 9.49M | 8.3% | SCHEDULE 13G/A ↗ |
| Feb 11, 2026 | SCHEDULE 13G/A (amended) | NSPR InspireMD Inc. | Aharon Gil | 10.99M | 9.2% | SCHEDULE 13G/A ↗ |
| Feb 11, 2026 | SCHEDULE 13G/A (amended) | NSPR InspireMD Inc. | Salamon Steven A J | 10.99M | 9.2% | SCHEDULE 13G/A ↗ |
| Feb 11, 2026 | SCHEDULE 13G/A (amended) | NSPR InspireMD Inc. | Rosalind Advisors, Inc. | 10.99M | 9.2% | SCHEDULE 13G/A ↗ |
| Feb 2, 2026 | SCHEDULE 13G/A (amended) | NSPR InspireMD Inc. | abrdn Inc. | 3.17M | 7.5% | SCHEDULE 13G/A ↗ |
| Feb 2, 2026 | SCHEDULE 13G/A (amended) | NSPR InspireMD Inc. | Aberdeen Group plc | 3.17M | 7.5% | SCHEDULE 13G/A ↗ |
| Nov 14, 2025 | SCHEDULE 13G/A (amended) | NSPR InspireMD Inc. | Daniel Mack | 4.26M | 10.0% | SCHEDULE 13G/A ↗ |
| Nov 14, 2025 | SCHEDULE 13G/A (amended) | NSPR InspireMD Inc. | Wilmot B. Harkey | 4.26M | 10.0% | SCHEDULE 13G/A ↗ |
| Nov 14, 2025 | SCHEDULE 13G/A (amended) | NSPR InspireMD Inc. | Nantahala Capital Management, LLC | 4.26M | 10.0% | SCHEDULE 13G/A ↗ |
| Nov 14, 2025 | SCHEDULE 13G/A (amended) | NSPR InspireMD Inc. | Nantahala Capital Partners Limited Partnership | 2.42M | 5.7% | SCHEDULE 13G/A ↗ |
| Nov 14, 2025 | SCHEDULE 13G/A (amended) | NSPR InspireMD Inc. | OrbiMed Advisors LLC | 2.13M | 4.1% | SCHEDULE 13G/A ↗ |
| Nov 14, 2025 | SCHEDULE 13G | NSPR InspireMD Inc. | Gregory Martinez | 2.44M | 5.8% | SCHEDULE 13G ↗ |
| Nov 14, 2025 | SCHEDULE 13G | NSPR InspireMD Inc. | Parkman Healthcare Partners Holdings GP LLC | 2.44M | 5.8% | SCHEDULE 13G ↗ |
| Nov 14, 2025 | SCHEDULE 13G | NSPR InspireMD Inc. | Parkman Healthcare Partners Holdings LP | 2.44M | 5.8% | SCHEDULE 13G ↗ |
| Nov 14, 2025 | SCHEDULE 13G | NSPR InspireMD Inc. | Parkman Healthcare Partners LLC | 2.44M | 5.8% | SCHEDULE 13G ↗ |
| Nov 14, 2025 | SCHEDULE 13G/A (amended) | NSPR InspireMD Inc. | Marshall Wace, LLP | 28.10M | 10.0% | SCHEDULE 13G/A ↗ |
| Nov 7, 2025 | SCHEDULE 13G | NSPR InspireMD Inc. | abrdn Inc. | 2.48M | 6.0% | SCHEDULE 13G ↗ |
| Nov 7, 2025 | SCHEDULE 13G | NSPR InspireMD Inc. | Aberdeen Group plc | 2.48M | 6.0% | SCHEDULE 13G ↗ |
| Oct 29, 2025 | SCHEDULE 13D/A (amended) | NSPR InspireMD Inc. | Craig Shore | 1.48M | 3.5% | SCHEDULE 13D/A ↗ |
| Oct 29, 2025 | SCHEDULE 13D | NSPR InspireMD Inc. | Michael A. Lawless | 3.61M | 8.6% | SCHEDULE 13D ↗ |
| Aug 11, 2025 | SCHEDULE 13G/A (amended) | NSPR InspireMD Inc. | Rosalind Opportunities Fund I L.P. | 1.50M | 3.5% | SCHEDULE 13G/A ↗ |
| Aug 11, 2025 | SCHEDULE 13G/A (amended) | NSPR InspireMD Inc. | Rosalind Master Fund L.P. | 9.49M | 9.9% | SCHEDULE 13G/A ↗ |
| Aug 11, 2025 | SCHEDULE 13G/A (amended) | NSPR InspireMD Inc. | Aharon Gil | 10.99M | 9.9% | SCHEDULE 13G/A ↗ |
| Aug 11, 2025 | SCHEDULE 13G/A (amended) | NSPR InspireMD Inc. | Salamon Steven A J | 10.99M | 9.9% | SCHEDULE 13G/A ↗ |
| Aug 11, 2025 | SCHEDULE 13G/A (amended) | NSPR InspireMD Inc. | Rosalind Advisors, Inc. | 10.99M | 9.9% | SCHEDULE 13G/A ↗ |
| Aug 11, 2025 | SCHEDULE 13G/A (amended) | NSPR InspireMD Inc. | Rosalind Opportunities Fund I L.P. | 1.50M | 0.1% | SCHEDULE 13G/A ↗ |
| Aug 11, 2025 | SCHEDULE 13G/A (amended) | NSPR InspireMD Inc. | Rosalind Master Fund L.P. | 9.49M | 8.4% | SCHEDULE 13G/A ↗ |
| Aug 11, 2025 | SCHEDULE 13G/A (amended) | NSPR InspireMD Inc. | Aharon Gil | 10.99M | 9.4% | SCHEDULE 13G/A ↗ |
| Aug 11, 2025 | SCHEDULE 13G/A (amended) | NSPR InspireMD Inc. | Salamon Steven A J | 10.99M | 9.4% | SCHEDULE 13G/A ↗ |
| Aug 11, 2025 | SCHEDULE 13G/A (amended) | NSPR InspireMD Inc. | Rosalind Advisors, Inc. | 10.99M | 9.4% | SCHEDULE 13G/A ↗ |
| Aug 11, 2025 | SCHEDULE 13G/A (amended) | NSPR InspireMD Inc. | Rosalind Opportunities Fund I L.P. | 1.50M | 0.1% | SCHEDULE 13G/A ↗ |
| Aug 11, 2025 | SCHEDULE 13G/A (amended) | NSPR InspireMD Inc. | Rosalind Master Fund L.P. | 9.49M | 8.4% | SCHEDULE 13G/A ↗ |
| Aug 11, 2025 | SCHEDULE 13G/A (amended) | NSPR InspireMD Inc. | Aharon Gil | 10.99M | 9.4% | SCHEDULE 13G/A ↗ |
| Aug 11, 2025 | SCHEDULE 13G/A (amended) | NSPR InspireMD Inc. | Salamon Steven A J | 10.99M | 9.4% | SCHEDULE 13G/A ↗ |
| Aug 11, 2025 | SCHEDULE 13G/A (amended) | NSPR InspireMD Inc. | Rosalind Advisors, Inc. | 10.99M | 9.4% | SCHEDULE 13G/A ↗ |
| Aug 6, 2025 | SCHEDULE 13G | NSPR InspireMD Inc. | Venkataraman Balaji | 2.14M | 5.1% | SCHEDULE 13G ↗ |
| Aug 6, 2025 | SCHEDULE 13G | NSPR InspireMD Inc. | Morgan Adam | 2.14M | 5.1% | SCHEDULE 13G ↗ |
The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 9:43 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances